Sharp Enters Validation Phase For New Clinical Packaging Facility In Wales

Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has begun the validation phase of Sharp UK, a £9.5M Clinical Services Centre of Excellence in Rhymney, Wales.

Development of the state-of-the-art, multiple-phase pharmaceutical manufacturing, packaging and distribution facility began in 2017 and is now complete.

The first phase of the expansion has involved renovation of a 10,200 square metre GMP facility on the 11-acre site which will offer clinical trial supplies packaging, labelling, distribution, QP services as well as secure drug storage.

Frank Lis, president of Sharp Clinical Services, said:
“Investing in new facilities and increasing our capacity enables Sharp to be even more responsive to customer requirements, while also meeting the growing demand for our services.”

Investment in the facility, which included £500,000 from the Welsh Government, enables the company to satisfy increased demand for Phase III clinical and commercial services. Once complete, it will triple Sharp’s clinical service capacity for the global pharmaceutical, biotech and clinical research sectors.

“Sharp UK will allow us to offer a broader range of integrated services from a world-class clinical facility. As such we are developing our manufacturing and analytical capabilities and adding automated bottling, blistering and serialization as well as Interactive Response Technology (IRT) services for clinical trial management. This means we will be able to offer full service support for larger global clinical studies from this new Clinical Services Centre of Excellence.”

The new facility will create 73 new jobs and safeguard a further 70 with support from the Welsh Government.

Sharp Services will be exhibiting at CPhI Worldwide in Madrid, Spain (Oct 9-11). Book a meeting online or visit the team on stand 3H30.

About Sharp
Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp is also a world leader in ’Track and Trace’ and serialization services, with over nine years’ experience in implementing serialized solutions for its pharma clients.

Sharp Clinical Services teams support pharma and biotech clients from phase I all the way through to commercialization. The company has over 32 depots globally, covering every region of the world with sites in the US and UK. Sharp Clinical Services offers a full complement of clinical trial services including analytical, formulation development, clinical manufacturing/packaging, IRT, storage and distribution as well as QP services for European distribution.

For more information, visit www.sharpservices.com